Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Net (2016 - 2021)

Historic Receivables - Net for Viridian Therapeutics, Inc.\DE (VRDN) over the last 8 years, with Q3 2021 value amounting to $1.0 million.

  • Viridian Therapeutics, Inc.\DE's Receivables - Net rose 165438.6% to $1.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.0 million, marking a year-over-year increase of 165438.6%. This contributed to the annual value of $108000.0 for FY2019, which is 35000.0% up from last year.
  • Per Viridian Therapeutics, Inc.\DE's latest filing, its Receivables - Net stood at $1.0 million for Q3 2021, which was up 165438.6% from $57000.0 recorded in Q3 2020.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Receivables - Net registered a high of $4.8 million during Q1 2018, and its lowest value of $4000.0 during Q1 2020.
  • For the 5-year period, Viridian Therapeutics, Inc.\DE's Receivables - Net averaged around $862600.0, with its median value being $539000.0 (2017).
  • As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Receivables - Net skyrocketed by 718000.0% in 2017, and later plummeted by 9987.52% in 2019.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Receivables - Net (Quarter) stood at $1.5 million in 2017, then crashed by 98.35% to $24000.0 in 2018, then soared by 3979.17% to $979000.0 in 2019, then tumbled by 94.18% to $57000.0 in 2020, then surged by 1654.39% to $1.0 million in 2021.
  • Its last three reported values are $1.0 million in Q3 2021, $57000.0 for Q3 2020, and $248000.0 during Q2 2020.